A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated

NCT06081530 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 3802876
DRUG: Placebo matching BI 3802876

Sponsor

Boehringer Ingelheim